Not applicableStudy completedNCT06768346What this trial is testingHyperthermic Intra-Vesical ChemotherapyWho this might be right forBladder Cancer Queen Mary University of London 259
Testing effectiveness (Phase 2)Active Not RecruitingNCT05531123What this trial is testingRisk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder CancerWho this might be right forBladder Cancer Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT02197897What this trial is testingEvaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder TumorsWho this might be right forBladder Cancer Baylor College of Medicine 15
Not applicableActive Not RecruitingNCT04100733What this trial is testingSurveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer MonitorWho this might be right forNon-muscle Invasive Bladder CancerUrinary Biomarker Jørgen Bjerggaard Jensen 392
Early research (Phase 1)Active Not RecruitingNCT05768347What this trial is testingIntravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBCWho this might be right forUrothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06957561What this trial is testingDisitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder CancerWho this might be right forBladder CancerMuscle-invasive Bladder Cancer Sun Yat-sen University 30
Testing effectiveness (Phase 2)UnknownNCT03759496What this trial is testingEfficacy of Durvalumab in Non-muscle-invasive Bladder CancerWho this might be right forBladder Cancer Hellenic GenitoUrinary Cancer Group 39
Not applicableStudy completedNCT03327883What this trial is testingRetrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder CancerWho this might be right forBladder Cancer National Cancer Institute (NCI) 15
Not applicableUnknownNCT04687254What this trial is testingGender-related Characteristics of Bladder Cancer TreatmentWho this might be right forBladder CancerRadical CystectomyMuscle-invasive Bladder Cancer University of Florence 500
Large-scale testing (Phase 3)Looking for participantsNCT06537154What this trial is testingNEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs TreatmentWho this might be right forMuscle-Invasive Bladder Carcinoma Peter Black 688
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386746What this trial is testingIntravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder CancerWho this might be right forUrothelial Carcinoma BladderBladder Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Large-scale testing (Phase 3)UnknownNCT03664869What this trial is testingElectromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder CancerWho this might be right forBladder Cancer Turku University Hospital 300
Early research (Phase 1)Looking for participantsNCT06173349What this trial is testingPLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder CancerWho this might be right forRecurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more University of California, Davis 12
Not applicableNot Yet RecruitingNCT07758881What this trial is testingEvaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC.Who this might be right forNon-muscle Invasive Bladder Cancer (NMIBC) Eight Medical International BV 30
Testing effectiveness (Phase 2)UnknownNCT05328336What this trial is testingPerioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter StudyWho this might be right forMuscle Invasive Bladder Cancer Urothelial Carcinoma Tianjin Medical University Second Hospital 74
Not applicableStudy completedNCT02969109What this trial is testingValidation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer Genomic Health®, Inc. 417
Testing effectiveness (Phase 2)Ended earlyNCT04430036What this trial is testingAGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder CancerWho this might be right forUrinary Bladder Neoplasms The University of Texas Health Science Center at San Antonio 4
Large-scale testing (Phase 3)Ended earlyNCT01410565What this trial is testingEfficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder CancerWho this might be right forBladder Cancer Spectrum Pharmaceuticals, Inc 66
Very early researchActive Not RecruitingNCT02812420What this trial is testingDurvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before SurgeryWho this might be right forHydronephrosisInfiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma, Micropapillary Variant+16 more M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT05951179What this trial is testingSafety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer Protara Therapeutics 131